International Journal of Immunology

| Peer-Reviewed |

Subcutaneous versus Sublingual Immunotherapy for Allergic Rhinitis therapy: Which Is Superior

Received: 08 June 2015    Accepted: 18 June 2015    Published: 02 July 2015
Views:       Downloads:

Share This Article

Abstract

Background: A randomized single-blinded study including 50 patients with allergic rhinitis. Objective: To evaluate and compare the efficacy of subcutaneous versus sublingual immunotherapy in treatment of allergic rhinitis. Materials and methods: Patients divided into Group A: twenty patients received subcutaneous immunotherapy and group B: twenty patients received sublingual immunotherapy for twelve months. We assessed skin prick test, symptom score and medication use, quality of life and nasal smear eosinophilic count before and after treatment. Results: In group A, clinical improvement was achieved in 100% of monosensitised and 62.5% of polysensitised patients, while in group B 100% of monosensitised and 60% of of polysensitised patients exhibited clinical improvement. Conclusion: The subcutaneous and sublingual routes of immunotherapy have similar efficacy.

DOI 10.11648/j.iji.20150303.13
Published in International Journal of Immunology (Volume 3, Issue 3, June 2015)
Page(s) 42-46
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Allergen Specific Immunotherapy, SCIT, SLIT, Allergic Rhinitis, Skin Prick Test, Nasal Smear Eosinophilia, Clinical Improvement

References
[1] Tahamiler R, Saritzali G, Canakcioglu S, Ozcora E, Dirican A. Comparison of the long-term efficacy of subcutaneous and sublingual immunotherapies in perennial rhinitis. ORL J Otorhinolaryngol Relat Spec. 2008; 70(3) 144-150.
[2] Walker, S. M., Durham, S. R., Till, S. J., Roberts, G., Corrigan, C. J., Leech, S. C., Krishna, M. T et al. Immunotherapy for allergic rhinitis. Clinical & Experimental Allergy 2011; 41: 1177–1200
[3] Pipet A, Botturi K, Pinot D, Vervloet D, Magnan A. Allergen-specific immunotherapy in allergic rhinitis and asthma. Mechanisms and proof of efficacy. Respir Med. 2009; 103:800–812.
[4] Canonica GW, Passalacqua G. Non injection routes for immunotherapy. J Allergy Clin Immunol 2003: 111: 437–48.
[5] Antu´ nez C, Mayorga C, Corzo JL, Jurado A, Torres MJ. Two year follow-up of immunological response in mite-allergic children treated with sublingual immunotherapy. Comparison with subcutaneous administration. Pediatr Allergy Immunol 2008: 19: 210–218.
[6] Brozek JL, Bousquet J, Baena-Cagnani CE, Bonini S, Canonica GW, Casale TB et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol. 2010; 126:466–476.
[7] Dreborg S. Histamine reactivity of the skin. Allergy 2001; 56:359-64.
[8] Kapp A, Demarteau N. Cost effectiveness of levocetirizine in chronic idiopathic urticaria: A pooled analysis of two randomised controlled trials. Clin Drug Investig. 2006; 26:1–11.
[9] Juniper EF, Thompson AK, Ferrie PJ, Roberts JN. Development and validation of the mini Rhinoconjunctivitis Quality of Life Questionnaire ClinExp Allergy 2000;30:132–140
[10] Canonica GW, Baena-Cagnani CE, Bousquet J, Bousquet PJ, Lockey RF, Malling HJ et al. Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. Allergy 2007; 62:317–324.
[11] Crobach M, Hermans J, Kaptein A, Kaptein A, Ridderikhoff J, Mulder J. Nasal smear eosinophilia for the diagnosis of allergic rhinitis and eosinophilic non-allergic rhinitis. Scand J Prim Health Care 1996;14:116-121
[12] Joint Task Force on Practice Parameters. Allergen immunotherapy: a practice parameter. American Academy of Allergy, Asthma and Immunology. American College of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol. 2003; 90:1–40.
[13] Cox L, Li JT, Nelson H, et al. Allergen immunotherapy: A practice parameter - second update. J Allergy Clin Immunol 2007; 120: S25-85
[14] Marogna M, Spadolini I, Massolo A, Canonica GW, Passalacqua G. Clinical, functional, and immunologic effects of sublingual immunotherapy in birch pollinosis: A 3-year randomized controlled study. J Allergy Clin Immunol 2005; 115: 1184-8.
[15] Dykewicz MS, Hamilos DL. Rhinitis and sinusitis. J Allergy Clin Immunol 2010; 125:S103-115
[16] Kleine-Tebbe J, Ribel M, Herold D. Safety of a standardised grass allergen tablet for sublingual immunotherapy a randomized, placebo-controlled trial,” Allergy 2006; 61(2): 181–184.
[17] Wilson DR, Lima MT, Durham SR. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy 2005; 60:4-12.
[18] Passalacqua G, Durham SR. Allergic Rhinitis and its Impact on Asthma update: Allergen immunotherapy. Journal of Allergy and Clinical Immunology 2007;119 (4):881 - 891
[19] Radulovic S, Calderon MA, Wilson D, Durham S. Sublingual immunotherapy for allergic rhinitis. Cochrane Database Syst Rev 2010; 12:CD002893.
[20] Kim KW, Kim EA, Kwon BC, Kim ES, Song TW, Sohn MH et al. Comparison of allergic indices in monosensitized and polysensitised patients with childhood asthma. J Korean Med Sci 2006; 21:1012-6.
[21] Wachholz PA, Durham SR. Mechanisms of immunotherapy: IgG revisited. Curr Opin Allergy Clin Immunol 2004 4(4):313-8.
[22] Eifan O, Akkoc T, Yildiz A, Keles S, Ozdemir C, Bahceciler NN et al. Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic/rhinitis children sensitized to house dust mite: an open randomized controlled trial. Clinical & Experimental Allergy 2010; 40:922–932.
[23] Frew AJ. Allergen immunotherapy. J Allergy Clin Immunol 2010 125: S306-313.
[24] Khinchi M. S, Poulse L. K, Carat F, André C, Hansen AB, Malling HJ. Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, double-blind, double-dummy study. Allergy 2004: 59: 45–53.
Author Information
  • Department of Otorhinolaryngology, Faculty of Medicine, Zagazig University, Zagazig, Egypt

  • Department of Otorhinolaryngology, Faculty of Medicine, Zagazig University, Zagazig, Egypt

  • Department of Otorhinolaryngology, Faculty of Medicine, Zagazig University, Zagazig, Egypt

  • Department of Internal Medicine, Allergy and Clinical Immunology, Faculty of Medicine, Ain Shams University, Cairo, Egypt

  • Department of Otorhinolaryngology, Faculty of Medicine, Ain Shams University, Cairo, Egypt

Cite This Article
  • APA Style

    Magdy Abdullah Sayedelahl, Naser Nagib Nasr, Mahmoud Hamed Akr, Dina Sayed Sheha, Tahany Mohamed Rabie. (2015). Subcutaneous versus Sublingual Immunotherapy for Allergic Rhinitis therapy: Which Is Superior. International Journal of Immunology, 3(3), 42-46. https://doi.org/10.11648/j.iji.20150303.13

    Copy | Download

    ACS Style

    Magdy Abdullah Sayedelahl; Naser Nagib Nasr; Mahmoud Hamed Akr; Dina Sayed Sheha; Tahany Mohamed Rabie. Subcutaneous versus Sublingual Immunotherapy for Allergic Rhinitis therapy: Which Is Superior. Int. J. Immunol. 2015, 3(3), 42-46. doi: 10.11648/j.iji.20150303.13

    Copy | Download

    AMA Style

    Magdy Abdullah Sayedelahl, Naser Nagib Nasr, Mahmoud Hamed Akr, Dina Sayed Sheha, Tahany Mohamed Rabie. Subcutaneous versus Sublingual Immunotherapy for Allergic Rhinitis therapy: Which Is Superior. Int J Immunol. 2015;3(3):42-46. doi: 10.11648/j.iji.20150303.13

    Copy | Download

  • @article{10.11648/j.iji.20150303.13,
      author = {Magdy Abdullah Sayedelahl and Naser Nagib Nasr and Mahmoud Hamed Akr and Dina Sayed Sheha and Tahany Mohamed Rabie},
      title = {Subcutaneous versus Sublingual Immunotherapy for Allergic Rhinitis therapy: Which Is Superior},
      journal = {International Journal of Immunology},
      volume = {3},
      number = {3},
      pages = {42-46},
      doi = {10.11648/j.iji.20150303.13},
      url = {https://doi.org/10.11648/j.iji.20150303.13},
      eprint = {https://download.sciencepg.com/pdf/10.11648.j.iji.20150303.13},
      abstract = {Background: A randomized single-blinded study including 50 patients with allergic rhinitis. Objective: To evaluate and compare the efficacy of subcutaneous versus sublingual immunotherapy in treatment of allergic rhinitis. Materials and methods: Patients divided into Group A: twenty patients received subcutaneous immunotherapy and group B: twenty patients received sublingual immunotherapy for twelve months. We assessed skin prick test, symptom score and medication use, quality of life and nasal smear eosinophilic count before and after treatment. Results: In group A, clinical improvement was achieved in 100% of monosensitised and 62.5% of polysensitised patients, while in group B 100% of monosensitised and 60% of of polysensitised patients exhibited clinical improvement. Conclusion: The subcutaneous and sublingual routes of immunotherapy have similar efficacy.},
     year = {2015}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Subcutaneous versus Sublingual Immunotherapy for Allergic Rhinitis therapy: Which Is Superior
    AU  - Magdy Abdullah Sayedelahl
    AU  - Naser Nagib Nasr
    AU  - Mahmoud Hamed Akr
    AU  - Dina Sayed Sheha
    AU  - Tahany Mohamed Rabie
    Y1  - 2015/07/02
    PY  - 2015
    N1  - https://doi.org/10.11648/j.iji.20150303.13
    DO  - 10.11648/j.iji.20150303.13
    T2  - International Journal of Immunology
    JF  - International Journal of Immunology
    JO  - International Journal of Immunology
    SP  - 42
    EP  - 46
    PB  - Science Publishing Group
    SN  - 2329-1753
    UR  - https://doi.org/10.11648/j.iji.20150303.13
    AB  - Background: A randomized single-blinded study including 50 patients with allergic rhinitis. Objective: To evaluate and compare the efficacy of subcutaneous versus sublingual immunotherapy in treatment of allergic rhinitis. Materials and methods: Patients divided into Group A: twenty patients received subcutaneous immunotherapy and group B: twenty patients received sublingual immunotherapy for twelve months. We assessed skin prick test, symptom score and medication use, quality of life and nasal smear eosinophilic count before and after treatment. Results: In group A, clinical improvement was achieved in 100% of monosensitised and 62.5% of polysensitised patients, while in group B 100% of monosensitised and 60% of of polysensitised patients exhibited clinical improvement. Conclusion: The subcutaneous and sublingual routes of immunotherapy have similar efficacy.
    VL  - 3
    IS  - 3
    ER  - 

    Copy | Download

  • Sections